WSR 14-10-049
[Filed May 1, 2014, 8:54 a.m.]
Original Notice.
Preproposal statement of inquiry was filed as WSR 13-19-059.
Title of Rule and Other Identifying Information: WAC 260-70-630 Threshold levels.
Hearing Location(s): Auburn City Council Chambers, 25 West Main, Auburn, WA 98002, on June 13, 2014, at 9:30 a.m.
Date of Intended Adoption: June 13, 2014.
Submit Written Comments to: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, e-mail, fax (360) 459-6461, by June 10, 2014.
Assistance for Persons with Disabilities: Contact Patty Sorby by June 10, 2014, TTY (360) 459-6462.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: Updates the threshold levels to current industry standards.
Reasons Supporting Proposal: To move closer to the RMTC and ARCI guidelines regarding permitted medications and the threshold levels to have consistency from jurisdiction to jurisdiction. Also, protects the equine and human participants to ensure that no substances are present in a horse at a level that may affect the performance.
Statutory Authority for Adoption: RCW 67.16.020.
Rule is not necessitated by federal law, federal or state court decision.
Name of Proponent: [Horse racing commission], governmental.
Name of Agency Personnel Responsible for Drafting, Implementation and Enforcement: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, (360) 459-6462.
No small business economic impact statement has been prepared under chapter 19.85 RCW. Not applicable.
A cost-benefit analysis is not required under RCW 34.05.328. Not applicable.
May 1, 2014
Douglas L. Moore
Executive Secretary
AMENDATORY SECTION (Amending WSR 13-07-045, filed 3/15/13, effective 4/15/13)
WAC 260-70-630 Threshold levels.
(1) Permitted medications.
(a) The following quantitative medications and/or metabolites are permissible in test samples up to the stated concentrations in urine:
((Acepromazine - 25 ng/ml urine
Albuterol - 1 ng/ml urine
Benzocaine - 50 ng/ml urine
Bupivacaine - 5 ng/ml urine
Betamethansone - 60 ng/ml urine
Clenbuterol - 25 pg/ml serum or plasma
Dexamethasone - 1.5 ng/ml serum or plasma
Diclofenac - 5 ng/ml serum or plasma
DMSO - 10 mc/ml serum or plasma
Firocoxib - 40 ng/ml serum or plasma
Glycopyrrolate - 3.5 pg/ml serum or plasma
Lidocaine - 50 ng/ml urine
Mepivacaine - 10 ng/ml urine
Methocarbamol - 1 ng/ml serum or plasma
Methylprednisolone - 1.3 ng/ml serum or plasma
Prednisolone - 2 ng/ml serum or plasma
Procaine - 25 ng/ml urine
Promazine - 25 ng/ml urine
Pyrilamine - 50 ng/ml urine
Salicylates - 750,000 ng/ml urine
Theobromine - 2000 ng/ml urine
Triamcinolone acetonide - 1 ng/ml serum or plasma))
Acepromazine - 25 ng/ml
Albuterol - 1 ng/ml
Bupivicaine - 5 ng/ml
Detomidine - 1 ng/ml
Mepivacaine - 10 ng/ml
Omeprozole - 1 ng/ml
Promazine - 25 ng/ml
Pyrilamine - 25 ng/ml
(b) The following quantitative medications and/or metabolites are permissible in test samples up to the stated concentrations in serum or plasma:
Betamethasone - 10 pg/ml
Butorphanol - 2 ng/ml
Clenbuterol - 25 pg/ml
Dantrolene - 100 pg/ml
Dexamethasone - 1 ng/ml
Diclofenac - 5 ng/ml
DMSO - 10 mc/ml
Firocoxib - 40 ng/ml
Glycopryrrolate - 3 pg/ml
Isoflupredone - 100 pg/ml
Lidocaine - 20 pg/ml
Methocarbamol - 1 ng/ml
Methylprednisolone - 1.3 ng/ml
Prednisolone - 1 ng/ml
*Procaine penicillin - 25 ng/ml
Triamcinolone - 100 pg/ml
Xylazine - 0.01 ng/ml
Administration of procaine penicillin to those horses entered must be reported to the commission and may require surveillance up to six hours prior to post time.
(c) The official urine or blood test sample may not contain more than one of the above substances, including their metabolites or analogs, and may not exceed the concentrations established in this rule.
(2) Environmental substances.
(a) Certain substances can be considered "environmental" in that they are endogenous to the horse or that they can arise from plants traditionally grazed or harvested as equine feed or are present in equine feed because of contamination or exposure during the cultivation, processing, treatment, storage, or transportation phases. Certain drugs are recognized as substances of human use and could therefore be found in a horse. The following substances are permissible in test samples up to the stated concentrations:
Arsenic - 0.3 mc/ml urine
Caffeine - 100 ng/ml serum or plasma
Benzoylecgonine - 50 ng/ml urine
Estranediol - 0.045 mc/ml free + conjugated (5a-oestrane-3β,17a-diol), in male horses, other than geldings
Hydrocortisone - 1 mc/ml urine
Methoxytyramine - 4 mc/ml, free + conjugated urine
Morphine Glucuronides - 50 ng/ml urine
Salicylate saliclic acid - 750 mc/ml serum or plasma
Theobromine - 2 mc/ml urine
(b) If a preponderance of evidence presented shows that a positive test is the result of environmental substance or inadvertent exposure due to human drug use, that evidence should be considered as a mitigating factor in any disciplinary action taken against the trainer.
(3) Androgenic-anabolic steroids.
(a) The following androgenic-anabolic steroids are permissible in test samples up to the stated concentrations:
((Stanozolol (Winstrol) - 1 ng/ml urine in all horses regardless of sex.))
Boldenone (Equipoise) - 15 ng/ml urine in intact males. No level is permitted in geldings, fillies or mares.
Nandrolone (Durabolin) - 1 ng/ml urine in geldings, fillies, and mares, and for nandrolone metabolite (5a-oestrane-3β,17a-diol) - 45 ng/ml urine in intact males.
Testosterone - 20 ng/ml urine in geldings. 55 ng/ml urine in fillies and mares. Samples from intact males will not be tested for the presence of testosterone.
(b) All other androgenic-anabolic steroids are prohibited in race horses.